Recently, Guangdong Tainkang Pharmaceutical Co., Ltd. (hereinafter referred to as “Tainkang”) announced the official appointment of Ms. Lin Zili as the company’s Vice General Manager. This personnel decision marks a significant step in Tainkang’s ongoing efforts to optimize its management team and strengthen corporate governance. Ms. Lin brings extensive experience in the pharmaceutical industry, having held key leadership roles at several well-known pharmaceutical companies. She possesses strong expertise in market operations, strategic planning, and team management. Her addition is expected to enhance Tainkang’s capabilities in product promotion, channel development, and brand influence.As an integrated pharmaceutical enterprise engaged in R&D, manufacturing, and sales, Tainkang has actively expanded its portfolio across innovative drugs, generics, and OTC products while broadening its presence in both domestic and international markets. The appointment of such a seasoned executive underscores the company’s commitment to high-quality growth and confidence in achieving its strategic objectives. Ms. Lin’s leadership is anticipated to drive upgrades in the company’s marketing systems and foster synergies across business units, helping Tainkang maintain a competitive edge in the dynamic pharmaceutical sector.Tainkang stated that it will continue strengthening its talent pipeline by attracting and retaining top-tier management and technical professionals, laying a solid foundation for sustainable long-term development.
近日，广东泰恩康医药股份有限公司（简称“泰恩康”）发布公告，正式聘任林姿丽女士为公司副总经理。此次人事任命是泰恩康在持续优化管理团队、强化企业治理结构背景下的重要举措。林姿丽女士拥有多年医药行业从业经验，曾在多家知名医药企业担任关键管理职务，具备丰富的市场运营、战略规划及团队管理能力。她的加入将进一步提升泰恩康在产品推广、渠道建设及品牌影响力等方面的综合实力。泰恩康作为一家集研发、生产、销售于一体的综合性医药企业，近年来积极布局创新药、仿制药及OTC产品线，并不断拓展国内外市场。此次引入资深高管，彰显了公司对高质量发展的重视，以及对未来战略目标实现的信心。林姿丽女士的履新，有望为公司在营销体系升级、业务协同发展等方面注入新动能，助力泰恩康在竞争激烈的医药行业中保持领先优势。公司表示，将持续完善人才梯队建设，吸引并留住优秀管理与技术人才，为长期可持续发展奠定坚实基础。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/5530.html